174 related articles for article (PubMed ID: 30877256)
1. p27 transcriptionally coregulates cJun to drive programs of tumor progression.
Yoon H; Kim M; Jang K; Shin M; Besser A; Xiao X; Zhao D; Wander SA; Briegel K; Morey L; Minn A; Slingerland JM
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7005-7014. PubMed ID: 30877256
[TBL] [Abstract][Full Text] [Related]
2. p27 as a Transcriptional Regulator: New Roles in Development and Cancer.
Razavipour SF; Harikumar KB; Slingerland JM
Cancer Res; 2020 Sep; 80(17):3451-3458. PubMed ID: 32341036
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J
Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140
[TBL] [Abstract][Full Text] [Related]
4. C-terminally phosphorylated p27 activates self-renewal driver genes to program cancer stem cell expansion, mammary hyperplasia and cancer.
Razavipour SF; Yoon H; Jang K; Kim M; Nawara HM; Bagheri A; Huang WC; Shin M; Zhao D; Zhou Z; Van Boven D; Briegel K; Morey L; Ince TA; Johnson M; Slingerland JM
Nat Commun; 2024 Jun; 15(1):5152. PubMed ID: 38886396
[TBL] [Abstract][Full Text] [Related]
5. ARHGAP17 suppresses tumor progression and up-regulates P21 and P27 expression via inhibiting PI3K/AKT signaling pathway in cervical cancer.
Guo Q; Xiong Y; Song Y; Hua K; Gao S
Gene; 2019 Apr; 692():9-16. PubMed ID: 30641218
[TBL] [Abstract][Full Text] [Related]
6. The PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed proliferation of human osteoblasts.
Li CJ; Chang JK; Chou CH; Wang GJ; Ho ML
Biochem Pharmacol; 2010 Mar; 79(6):926-37. PubMed ID: 19883628
[TBL] [Abstract][Full Text] [Related]
7. Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.
McCampbell AS; Mittelstadt ML; Dere R; Kim S; Zhou L; Djordjevic B; Soliman PT; Zhang Q; Wei C; Hursting SD; Lu KH; Broaddus RR; Walker CL
Curr Mol Med; 2016; 16(3):252-65. PubMed ID: 26917264
[TBL] [Abstract][Full Text] [Related]
8. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
9. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
[TBL] [Abstract][Full Text] [Related]
10. Non-CDK-bound p27 (p27(NCDK)) is a marker for cell stress and is regulated through the Akt/PKB and AMPK-kinase pathways.
Björklund MA; Vaahtomeri K; Peltonen K; Viollet B; Mäkelä TP; Band AM; Laiho M
Exp Cell Res; 2010 Mar; 316(5):762-74. PubMed ID: 20036235
[TBL] [Abstract][Full Text] [Related]
11. p27(Kip1) signaling: Transcriptional and post-translational regulation.
Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q
Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
13. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.
Prasad SB; Yadav SS; Das M; Modi A; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
Cell Oncol (Dordr); 2015 Jun; 38(3):215-25. PubMed ID: 25821107
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of P27 by AKT is required for inhibition of cell cycle progression in cholangiocarcinoma.
Chen R; He F; He H; York JP; Liu W; Xia X
Dig Liver Dis; 2018 May; 50(5):501-506. PubMed ID: 29428513
[TBL] [Abstract][Full Text] [Related]
15. Lucidone Promotes the Cutaneous Wound Healing Process via Activation of the PI
Yang HL; Tsai YC; Korivi M; Chang CT; Hseu YC
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):151-168. PubMed ID: 27816443
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
17. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.
Grimmler M; Wang Y; Mund T; Cilensek Z; Keidel EM; Waddell MB; Jäkel H; Kullmann M; Kriwacki RW; Hengst L
Cell; 2007 Jan; 128(2):269-80. PubMed ID: 17254966
[TBL] [Abstract][Full Text] [Related]
18. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
Yakes FM; Chinratanalab W; Ritter CA; King W; Seelig S; Arteaga CL
Cancer Res; 2002 Jul; 62(14):4132-41. PubMed ID: 12124352
[TBL] [Abstract][Full Text] [Related]
19. The role of p27(Kip1) phosphorylation at serine 10 in the migration of malignant glioma cells in vitro.
Wang D; He F; Zhang L; Zhang F; Wang Q; Qian X; Pan X; Meng J; Peng C; Shen A; Chen J
Neoplasma; 2011; 58(1):65-73. PubMed ID: 21067268
[TBL] [Abstract][Full Text] [Related]
20. Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition.
Salomon A; Keramidas M; Maisin C; Thomas M
Oncotarget; 2015 May; 6(13):11421-33. PubMed ID: 25823656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]